Presidio Capital Management, LLC
Position in INBX — Inhibrx Biosciences, Inc.
CIK 1931750
SAN DIEGO, CA
Position in INBX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$321,581
+$93,403 QoQ
Shares Held
3,394
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#107
of 161 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Presidio Capital Management, LLC holds $386,402 across 2 Biotechnology names. INBX ranks #1 (83.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
This page
|
3,394 | $321,581 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
|
34,664 | $64,821 |
All Filings in INBX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321,581 | 3,394 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $228,178 | 3,394 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $268,126 | 3,394 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||